HR6705-118

Introduced

To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes.

118th Congress Introduced Dec 11, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Agriculture, Immigration.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H191362F184214C1180D36568B6AD3B28: 1. Short title This Act may be cited as the Effective Screening and Testing for Tuberculosis Act.
  • Section H03662EF3F94A4C22B78B0506C8BC23F8: 2. Treatment of certain tests for tuberculosis as breakthrough devices The Secretary of Health and Human Services shall treat a device as a breakthrough device...
  • Section HDA493359B37748108C4267D30F11E4F4: 3. Requiring certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis The Secretary of Health and...
  • Section H4C7B09F1A61D4A73805010C5E7EADAE9: 4. Guidance on current good tissue practice and additional requirements for manufacturers of human cells, tissues, and cellular and tissue-based products Not...
  • Section H6048DFB4F580432A9FEAF8FDDB278B93: 5. Compliance with CUTGO No additional funds are authorized to be appropriated to carry out this Act, and this Act shall be carried out using amounts otherwise...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Agriculture, Immigration

Primary Purpose

This bill, To require the Secretary of Health and Human Services to treat certain tests for tuberculosis as breakthrough devices eligible for expedited development and priority review, to require certain establishments that perform donor screening or testing to screen or test for active and latent tuberculosis, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Agriculture Immigration

Whole bill

Identified Gains
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
health care providers and patients:
Identified Costs
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:
health care providers and patients:

Legislative Progress

Introduced
Introduced Committee Passed
Dec 11, 2023

Mr. Moolenaar (for himself, Mrs. Dingell, and Mr. Correa) introduced …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Agriculture Immigration
Actor Mappings
"the_commission"
→ The commission identified in the operative section
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology